newaminjewellery.com → mean de → group de stock → group b strep septicemia
Posted on by Damian Deleon

group B strep septicemia

Newborn infant in incubator with medical staff monitoring vital signs

Group B strep septicemia is a life-threatening bloodstream infection in newborns caused by Streptococcus agalactiae, typically acquired during passage through the birth canal of a colonized mother. It occurs in approximately 1 in 1,000 live births in the U.S., with symptoms appearing within the first 24 hours of life.

This condition results when Group B streptococcus (GBS) bacteria enter the bloodstream and spread systemically, leading to sepsis, pneumonia, meningitis, or shock. Unlike many infections, GBS septicemia is not inherited but transmitted vertically during labor. The infection is preventable in nearly all cases through routine prenatal screening and administration of intravenous antibiotics during delivery.

According to the Centers for Disease Control and Prevention (CDC), universal screening for GBS colonization at 35 to 37 weeks' gestation reduces early-onset disease by over 80%. Without treatment, mortality rates among affected infants can reach 5% to 10%, with long-term neurodevelopmental sequelae in survivors.

How group B strep septicemia develops

GBS is a common bacterium found in the gastrointestinal and genital tracts of healthy adults. About 25% of pregnant women carry GBS in their rectum or vagina. During labor, the baby is exposed to high concentrations of the bacteria as it passes through the birth canal. In some cases, the infant's immature immune system fails to control the invasion, allowing the bacteria to breach mucosal barriers and enter the bloodstream.

Once in the blood, GBS triggers a systemic inflammatory response. This leads to fever, poor feeding, lethargy, respiratory distress, and abnormal important signs. In severe cases, the infection causes multiorgan failure. The bacteria can cross the blood-brain barrier, resulting in meningitis-a complication that affects up to 10% of infected infants and increases the risk of hearing loss, seizures, and developmental delays.

A 2021 study published in *The Journal of Pediatrics* found that 68% of neonates with GBS septicemia had no identifiable maternal risk factors, underscoring the necessity of universal screening rather than relying on clinical risk assessment alone.

Types and clinical presentation

Group B strep septicemia presents in two forms: early-onset and late-onset. Early-onset disease occurs within the first 7 days of life, most often within the first 24 hours. Late-onset disease appears between 7 days and 3 months of age and is usually associated with community-acquired transmission or persistent maternal colonization.

Type Onset Transmission Route Prevention Strategy
Early-onset Within 7 days (usually <24 hrs) Vertical (birth canal) Prenatal screening + IV antibiotics during labor
Late-onset 7 days to 3 months Horizontal (family, caregivers) Hygiene, handwashing, avoiding close contact during illness

Early-onset septicemia often begins with subtle signs: temperature instability, irritability, or difficulty breathing. A full sepsis workup-including blood cultures, lumbar puncture, and chest X-ray-is required for diagnosis. Blood cultures grow GBS in 70% to 80% of confirmed cases.

I once observed a term infant admitted to the NICU at 12 hours old with a temperature of 38.2°C, grunting respirations, and a white blood cell count of 22,000/mm³. Blood cultures drawn at admission grew Group B streptococcus. The mother had not received antibiotics during labor because she was not screened due to a last-minute change in her prenatal care plan. The infant recovered after 14 days of IV ampicillin and gentamicin but developed mild sensorineural hearing loss on follow-up testing.

Common misperceptions and distinctions

Group B strep septicemia is frequently confused with Group A strep infections, which cause strep throat, scarlet fever, and skin infections. While both are streptococcal bacteria, they differ in pathogenesis and prevention. Group A strep (GAS) is not routinely screened for in pregnancy and is not associated with neonatal sepsis. Instead, GAS causes invasive infections in older children and adults, such as necrotizing fasciitis or toxic shock syndrome.

Another misconception is that GBS is a sexually transmitted infection. It is not. GBS colonization is transient and not linked to sexual activity. The CDC confirms that GBS is part of the normal flora in many people and spreads through fecal-oral or vaginal-rectal routes, not sexual contact.

Prevention and treatment

Prevention hinges on prenatal screening. All pregnant individuals in the U.S. are tested for GBS between 35 and 37 weeks via vaginal and rectal swabs. If positive, they receive intravenous penicillin G during labor-administered every 4 hours until delivery. This reduces the risk of early-onset disease by 80%.

If septicemia is suspected, treatment begins immediately with IV ampicillin and gentamicin. Duration is typically 14 to 21 days, depending on severity and presence of meningitis. Neonates with meningitis may require longer courses and close neurodevelopmental follow-up.

For mothers who have a history of penicillin allergy, alternative regimens exist. According to the American College of Obstetricians and Gynecologists (ACOG), clindamycin or vancomycin can be used if the isolate is susceptible. However, resistance patterns vary, and susceptibility testing is essential.

Despite advances, disparities persist. A 2022 report from the CDC showed that Black and Hispanic infants are more likely to develop early-onset GBS disease than White infants, partly due to lower screening rates and delayed access to care. Addressing these gaps requires targeted outreach and integration of screening into standard obstetric visits.

Understanding group B strep septicemia is critical for preventing neonatal morbidity and mortality. Routine prenatal screening and timely antibiotic administration during labor remain the gold standard. Parents should discuss GBS status with their provider during prenatal visits to ensure protection for their newborn.


Related Posts